First Time Loading...

Design Therapeutics Inc
NASDAQ:DSGN

Watchlist Manager
Design Therapeutics Inc Logo
Design Therapeutics Inc
NASDAQ:DSGN
Watchlist
Price: 4.47 USD 1.36%
Updated: May 20, 2024

Design Therapeutics Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Design Therapeutics Inc
Other Equity Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
Design Therapeutics Inc
NASDAQ:DSGN
Other Equity
$62k
CAGR 3-Years
-32%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Other Equity
-$2.5B
CAGR 3-Years
9%
CAGR 5-Years
0%
CAGR 10-Years
-19%
Gilead Sciences Inc
NASDAQ:GILD
Other Equity
$69m
CAGR 3-Years
22%
CAGR 5-Years
-15%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Other Equity
-$190m
CAGR 3-Years
39%
CAGR 5-Years
14%
CAGR 10-Years
-4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Other Equity
$27.4m
CAGR 3-Years
N/A
CAGR 5-Years
35%
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Other Equity
-$77.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Design Therapeutics Inc's Other Equity?
Other Equity
62k USD

Based on the financial report for Dec 31, 2023, Design Therapeutics Inc's Other Equity amounts to 62k USD.

What is Design Therapeutics Inc's Other Equity growth rate?
Other Equity CAGR 3Y
-32%

The average annual Other Equity growth rates for Design Therapeutics Inc have been -32% over the past three years .